BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34471382)

  • 1. Prognostic Value of an m
    Li H; Jiang H; Huang Z; Chen Z; Chen N
    Cancer Manag Res; 2021; 13():6673-6687. PubMed ID: 34471382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of m
    Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
    Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.
    Zhang L; Su Z; Hong F; Wang L
    Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of m
    Wang J; Zhang C; He W; Gou X
    Front Oncol; 2020; 10():3. PubMed ID: 32038982
    [No Abstract]   [Full Text] [Related]  

  • 5. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a m
    Chen J; Yu K; Zhong G; Shen W
    Cancer Cell Int; 2020; 20():157. PubMed ID: 32419773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma.
    Wang Z; Zhang M; Seery S; Zheng G; Wang W; Zhao Y; Wang X; Zhang Y
    Oncol Lett; 2022 Aug; 24(2):250. PubMed ID: 35761938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N
    Zhang Y; Yao Y; Qi X; Li J; Liu M; Che X; Xu Y; Wu G
    J Immunol Res; 2021; 2021():6617841. PubMed ID: 33628845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation regulator-based signature for predicting clear cell renal cell carcinoma prognosis.
    Gong W; Yang R; Wang Z
    Am J Transl Res; 2023; 15(4):2443-2459. PubMed ID: 37193150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtypes of m
    Guan B; Ren F; Shan W; Zhang S
    Transl Cancer Res; 2022 Mar; 11(3):508-518. PubMed ID: 35402182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
    Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
    Front Genet; 2022; 13():816173. PubMed ID: 35281843
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic Characteristics and Immune Effects of N
    Li L; Tao Z; Zhao Y; Li M; Zheng J; Li Z; Chen X
    Front Genet; 2022; 13():864383. PubMed ID: 35571068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
    Xu LC; Pan JX; Pan HD
    Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel m
    Chen S; Zhang N; Zhang E; Wang T; Jiang L; Wang X; Zheng J
    Front Cell Dev Biol; 2020; 8():616972. PubMed ID: 33553151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.
    Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X
    Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 20. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
    Jiang W; Guo Q; Wang C; Zhu Y
    Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.